D-0494-2026 Class III Ongoing
FDA drug recall D-0494-2026 was initiated by American Regent, Inc. on Apr 16, 2026 and is designated Class III. Reason for recall: Labeling: Missing Label The recall status is ongoing. Affected quantity: 74,040 Single Dose Vials.
Recall details
- Product Type
- Drugs
- Report Date
- May 6, 2026
- Initiation Date
- Apr 16, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 74,040 Single Dose Vials
Product description
Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01
Reason for recall
Labeling: Missing Label
Distribution pattern
U.S. Nationwide
Code information
Lot 24159N0C0, Exp. June 30, 2026 Lot 25193N0C0, Exp. July 31, 2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0494-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026